Long-Term Safety and Efficacy of Fulranumab in Patients With Moderate-To-Severe Osteoarthritis Pain: A Phase II Randomized, Double-Blind, Placebo-Controlled Extension Study
Arthritis and Rheumatology- United Kingdom
doi 10.1002/art.39943
Full Text
Abstract
Available in
Date
March 8, 2017
Authors
Publisher
Wiley